Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Thalidomide and its derivatives are the only protein degraders currently used in clinical practice. This tutorial review provides an overview of the mechanism of action of thalidomide-based degraders and their future perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
Self-citationLenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Krönke, J., Udeshi, N. D., Narla, A., Grauman, P., Hurst, S. N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014) · Science · doi:10.1126/science.1244851 · Cited by 1,879
Phthalimide conjugation as a strategy for in vivo target protein degradation
Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760
Mechanism of auxin perception by the TIR1 ubiquitin ligase
Tan, X., Calderon-Villalobos, L. I. A., Sharon, M., Zheng, C., Robinson, C. V., Estelle, M., & Zheng, N. (2007) · Nature · doi:10.1038/nature05731 · Cited by 1,688
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Lu, G., Middleton, R. E., Sun, H., Naniong, M., Ott, C. J., Mitsiades, C. S., Wong, K.-K., Bradner, J. E., & Kaelin, W. G. (2014) · Science · doi:10.1126/science.1244917 · Cited by 1,583
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Research works printed but not linked: 60
- Yamamoto, 2020, Nat. Chem. Biol., 16, 1208, 10.1038/s41589-020-0645-3 · DOI
- Shimizu, 2021, Commun. Biol., 4, 277, 10.1038/s42003-021-01785-z · DOI
- Renneville, 2021, Blood Cancer Discovery, 2, 250, 10.1158/2643-3230.BCD-20-0105 · DOI
- Yamanaka, 2022, Nat. Commun., 13, 183, 10.1038/s41467-021-27818-z · DOI
- Burley, 1962, Lancet, 279, 271, 10.1016/S0140-6736(62)91217-5 · DOI · Paper page
- Lenz, 1988, Teratology, 38, 203, 10.1002/tera.1420380303 · DOI · Paper page
- Sheskin, 1965, Clin. Pharm. Ther., 6, 303, 10.1002/cpt196563303 · DOI · Paper page
- Sampaio, 1991, J. Exp. Med., 173, 699, 10.1084/jem.173.3.699 · DOI · Paper page
- Mchugh, 1995, Clin. Exp. Immunol., 99, 160, 10.1111/j.1365-2249.1995.tb05527.x · DOI · Paper page
- Dredge, 2002, J. Immunol., 168, 4914, 10.4049/jimmunol.168.10.4914 · DOI · Paper page
- Marriott, 2002, Clin. Exp. Immunol., 130, 75, 10.1046/j.1365-2249.2002.01954.x · DOI · Paper page
- Nishio, 2008, Colloids Surf., B, 64, 162, 10.1016/j.colsurfb.2008.01.013 · doi:10.1016/j.colsurfb.2008.01.013
- Masaike, 2009, Mol. Pharmacol., 77, 262, 10.1124/mol.109.059006 · doi:10.1124/mol.109.059006
- Azuma, 2008, PLoS One, 3, e3070, 10.1371/journal.pone.0003070 · DOI
- Kuramori, 2009, Biochem. Biophys. Res. Commun., 379, 519, 10.1016/j.bbrc.2008.12.103 · doi:10.1016/j.bbrc.2008.12.103
- Zhu, 2011, Blood, 118, 4771, 10.1182/blood-2011-05-356063 · DOI · Paper page
- Broyl, 2013, Blood, 121, 624, 10.1182/blood-2012-06-438101 · DOI · Paper page
- Heintel, 2013, Br. J. Haematol., 161, 695, 10.1111/bjh.12338 · DOI · Paper page
- Zhu, 2014, Blood, 124, 536, 10.1182/blood-2014-02-557819 · DOI · Paper page
- Krönke, 2016, Leukemia, 31, 1363, 10.1038/leu.2016.384 · DOI · Paper page
- Misiewicz-Krzeminska, 2020, Blood Adv., 4, 6023, 10.1182/bloodadvances.2020002711 · DOI
- Amit, 2002, Genes Dev., 16, 1066, 10.1101/gad.230302 · DOI · Paper page
- Bidère, 2008, Nature, 458, 92, 10.1038/nature07613 · DOI · Paper page
- Corral, 1999, J. Immunol., 163, 380, 10.4049/jimmunol.163.1.380 · DOI · Paper page
- Schafer, 2003, J. Pharmacol. Exp. Ther., 305, 1222, 10.1124/jpet.102.048496 · DOI · Paper page
- Dredge, 2002, J. Immunol., 168, 4914, 10.4049/jimmunol.168.10.4914 · DOI · Paper page
- Wu, 2008, Clin. Cancer Res., 14, 4650, 10.1158/1078-0432.CCR-07-4405 · DOI · Paper page
- Gandhi, 2013, Br. J. Haematol., 164, 811, 10.1111/bjh.12708 · DOI · Paper page
- Jacques, 2015, Proc. Natl. Acad. Sci. U. S. A., 112, E1471, 10.1073/pnas.1417832112 · DOI
- Mori, 2018, Sci. Rep., 8, 1294, 10.1038/s41598-018-19202-7 · DOI
- Hirose, 2020, Proc. Natl. Acad. Sci. U. S. A., 117, 23106, 10.1073/pnas.1917701117 · DOI
- Kohlhase, 2002, Hum. Mol. Genet., 11, 2979, 10.1093/hmg/11.23.2979 · DOI · Paper page
- Kohlhase, 2004, Birth Defects Res., Part A, 70, 550, 10.1002/bdra.20050 · DOI
- Belair, 2020, Sci. Rep., 10, 2864, 10.1038/s41598-020-59542-x · DOI
- Mills, 1999, Nature, 398, 708, 10.1038/19531 · DOI · Paper page
- Yang, 2002, Trends Genet., 18, 90, 10.1016/S0168-9525(02)02595-7 · DOI · Paper page
- Yang, 1999, Nature, 398, 714, 10.1038/19539 · DOI · Paper page
- Chen, 2015, PLoS One, 10, e0143878, 10.1371/journal.pone.0143878 · doi:10.1371/journal.pone.0143878
- Barna, 2000, Nat. Genet., 25, 166, 10.1038/76014 · DOI · Paper page
- Chamberlain, 2014, Nat. Struct. Mol. Biol., 21, 803, 10.1038/nsmb.2874 · DOI · Paper page
- Li, 2006, Cell, 124, 105, 10.1016/j.cell.2005.10.033 · DOI · Paper page
- Sheereen, 2017, J. Med. Genet., 54, 236, 10.1136/jmedgenet-2016-104117 · DOI · Paper page
- Petzold, 2016, Nature, 532, 127, 10.1038/nature16979 · DOI · Paper page
- Boichenko, 2018, ACS Omega, 3, 11163, 10.1021/acsomega.8b00959 · DOI
- Heim, 2019, J. Med. Chem., 62, 6615, 10.1021/acs.jmedchem.9b00454 · DOI
- Heim, 2022, Acta Crystallogr., Sect. D: Struct. Biol., 78, 290, 10.1107/S2059798322000092 · DOI
- Maiwald, 2020, ACS Med. Chem. Lett., 12, 74, 10.1021/acsmedchemlett.0c00440 · DOI
- Burslem, 2018, ChemMedChem, 13, 1508, 10.1002/cmdc.201800271 · DOI · Paper page
- Brent, 1964, J. Pediatr., 64, 762, 10.1016/S0022-3476(64)80626-0 · DOI
- Chesi, 2012, Blood, 120, 376, 10.1182/blood-2012-02-412783 · DOI · Paper page
- Gemechu, 2018, Proc. Natl. Acad. Sci. U. S. A., 115, 11802, 10.1073/pnas.1814446115 · DOI · Paper page
- Winter, 2015, Science, 348, 1376, 10.1126/science.aab1433 · DOI · Paper page
- Schiedel, 2017, J. Med. Chem., 61, 482, 10.1021/acs.jmedchem.6b01872 · DOI · Paper page
- Su, 2019, J. Med. Chem., 62, 7575, 10.1021/acs.jmedchem.9b00871 · DOI · Paper page
- Liu, 2020, Sci. Adv., 6, eaay5154, 10.1126/sciadv.aay5154 · DOI · Paper page
- Reynders, 2020, Sci. Adv., 6, eaay5064, 10.1126/sciadv.aay5064 · DOI · Paper page
- Liu, 2014, Nat. Commun., 5, 3924, 10.1038/ncomms4924 · DOI
- Kwon, 2019, FASEB J., 33, 6539, 10.1096/fj.201801766RRR · DOI
- Jo, 2005, J. Neurochem., 94, 1212, 10.1111/j.1471-4159.2005.03344.x · DOI · Paper page
- Song, 2018, PLoS Genet., 14, e1007165, 10.1371/journal.pgen.1007165 · DOI
Cited by
Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblon
Heim, C., Spring, A.-K., Kirchgäßner, S., Schwarzer, D., & Hartmann, M. D. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.11.001 · Cited by 51
Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders
Kroupova, A., Spiteri, V. A., Rutter, Z. J., Furihata, H., Darren, D., Ramachandran, S., Chakraborti, S., Haubrich, K., Pethe, J., Gonzales, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52871-9 · Cited by 47
Eladl, O. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117297 · Cited by 44
Costa, B. A., Mouhieddine, T. H., Ortiz, R. J., & Richter, J. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104040 · Cited by 18
Scalable insect cell expression and purification screening applied to CRL4-DCAF substrate receptors
(2026) · doi:10.1016/j.pep.2026.106907
Metadata
- Authors
- Yamamoto, J., Ito, T., Yamaguchi, Y., & Handa, H.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 51
- Issue
- 15
- Pages
- 6234-6250
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W4284888202
- Cited by
- 158
- References
- 56
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Japan Society for the Promotion of Science (18H05502, 20H03182, 20K08741, 21H02955)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.